PB
Psyence Biomedical Ltd.
PBM · NASDAQ
$6.63 +4.83% (+$0.31)
1M +57.11%
Market Cap $126.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.01x
PEG N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 58.93%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 39.48%
Asset turnover 0.00x
ROIC 36.81%
Debt
69 /100
Low Current ratio 14.62x
Int. coverage -727.46x
Debt/Equity 0.00x
Stability
6 /100
Unstable EPS volatility 666.33%
Profitable years 0
Beta 1.72x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PBM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jody Aufrichtig
Employees
12
Headquarters
Toronto